← Search

Data · dataset · 2026

<p>XXX.</p>

Listed in UCL Research Data Repository

<div><p>Systemic lupus erythematosus (SLE) is characterized by autoantibody production alongside inflammatory manifestations, including nephritis.

Description

In SLE, infections are frequent and associated with disease flares, increasing morbidity and mortality. Additionally, dysbiosis, often marked by overgrowth of Pseudomonadota, is a prominent feature of SLE and lupus nephritis.

We previously demonstrated that complexes of DNA and curli, an amyloidogenic protein from biofilms of Pseudomonadota, including <i>Salmonella</i> Typhimurium and <i>E. coli</i>, can induce anti-dsDNA and anti-chromatin autoantibody responses. Here, we assessed the effects of curli administration or <i>Salmonella</i> infection on autoimmune manifestations in wild-type and lupus-prone mice. A multiplex autoantibody assay showed increased levels of anti-C1q antibodies in curli-treated C57BL/6 and lupus-prone NZBxW/F1 mice compared to PBS-treated controls.

Read the rest (2 more)

An anti-C1q-specific ELISA confirmed the presence of anti-C1q antibodies in C57BL/6 mice after treatment with curli/DNA, extracted from <i>E. coli</i> or <i>Salmonella</i> biofilms, or infection with <i>Salmonella</i>. Prior to the onset of spontaneous disease, sera from young NZBxW/F1 mice, injected with curli, demonstrated increased anti-dsDNA and anti-C1q antibody responses compared to PBS-treated controls; however, no differences were found in older mice, post-onset, when autoantibody levels were already high.

In MRL/lpr mice, curli treatment significantly exacerbated anti-C1q antibody production regardless of age and disease stage, compared to PBS-treated controls. While curli treatment did not significantly affect proteinuria in either model, curli-treatment of MRL/lpr mice significantly increased C1q deposition in glomeruli. This study uncovers a novel mechanism for the induction of anti-C1q autoantibodies and how infection or dysbiosis may exacerbate renal disease in SLE.</p></div>

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Disease 75%
Provenance · 1 source records, 15 field assertions
SourceKeyLast seenRaw
UCL Research Data Repositoryoai:figshare.com:article/3404925812 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0
concepts[disease].local:disease:diseaseenrichment · rdr ucl ac ukkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].anzsrc:field:310706mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Virology']
concepts[field].anzsrc:field:320211mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Infectious Diseases']
concepts[field].anzsrc:group:3101mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Cell Biology']
concepts[field].anzsrc:group:3103mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Ecology']
concepts[field].anzsrc:group:3107mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Microbiology']
concepts[field].anzsrc:group:3204mapping · rdr ucl ac ukvocabulary-mapper@1.0.0keywords['Immunology']
concepts[field].local:field:earth-environmentalmapping · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0
concepts[field].local:field:life-sciencesmapping · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0
concepts[field].local:field:medicine-healthmapping · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0
descriptionsource · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0/metadata/dc/description
licensesource · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0/metadata/dc/rights
publication_datesource · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0
titlesource · rdr ucl ac ukconnector:rdr_ucl_ac_uk@1.0.0/metadata/dc/title